Analysts expect Exponent, Inc. (NASDAQ:EXPO) to post sales of $94.25 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Exponent’s earnings, with the lowest sales estimate coming in at $93.89 million and the highest estimate coming in at $94.60 million. Exponent posted sales of $95.62 million during the same quarter last year, which suggests a negative year over year growth rate of 1.4%. The business is expected to report its next earnings report on Thursday, July 18th.

According to Zacks, analysts expect that Exponent will report full year sales of $381.03 million for the current year, with estimates ranging from $380.70 million to $381.35 million. For the next fiscal year, analysts forecast that the business will report sales of $406.38 million, with estimates ranging from $406.25 million to $406.50 million. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow Exponent.

Exponent (NASDAQ:EXPO) last posted its earnings results on Thursday, April 18th. The business services provider reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.07. Exponent had a return on equity of 23.10% and a net margin of 19.53%. The firm had revenue of $93.40 million for the quarter, compared to analyst estimates of $93.52 million. During the same quarter in the prior year, the company earned $0.75 EPS. Exponent’s revenue was up 3.0% on a year-over-year basis.

A number of equities research analysts recently issued reports on the company. Zacks Investment Research raised Exponent from a “hold” rating to a “strong-buy” rating and set a $64.00 target price on the stock in a research note on Tuesday, April 23rd. BidaskClub upgraded Exponent from a “buy” rating to a “strong-buy” rating in a report on Wednesday, March 27th. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $56.00 price target on shares of Exponent in a report on Friday, February 1st. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. Exponent presently has a consensus rating of “Buy” and a consensus price target of $61.33.

In other Exponent news, Director Carol Lindstrom sold 1,800 shares of the business’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $56.92, for a total value of $102,456.00. Following the completion of the transaction, the director now directly owns 3,212 shares in the company, valued at approximately $182,827.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Harri Kytomaa sold 2,366 shares of the company’s stock in a transaction on Friday, February 22nd. The stock was sold at an average price of $56.27, for a total value of $133,134.82. Following the sale, the insider now owns 3,816 shares of the company’s stock, valued at $214,726.32. The disclosure for this sale can be found here. Insiders own 2.30% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the company. FMR LLC boosted its position in Exponent by 39.8% during the 1st quarter. FMR LLC now owns 993,288 shares of the business services provider’s stock worth $57,333,000 after purchasing an additional 282,530 shares during the period. BlueCrest Capital Management Ltd purchased a new stake in Exponent during the 1st quarter worth $254,000. RMB Capital Management LLC boosted its position in Exponent by 194.3% during the 1st quarter. RMB Capital Management LLC now owns 16,739 shares of the business services provider’s stock worth $966,000 after purchasing an additional 11,051 shares during the period. One Wealth Advisors LLC purchased a new stake in Exponent during the 1st quarter worth $161,000. Finally, Morgan Stanley boosted its position in Exponent by 25.2% during the 1st quarter. Morgan Stanley now owns 196,904 shares of the business services provider’s stock worth $11,364,000 after purchasing an additional 39,574 shares during the period. Institutional investors and hedge funds own 89.84% of the company’s stock.

EXPO stock traded down $0.33 on Tuesday, reaching $55.74. The company had a trading volume of 2,344 shares, compared to its average volume of 217,216. Exponent has a 1 year low of $44.44 and a 1 year high of $59.80. The firm has a market cap of $2.88 billion, a P/E ratio of 44.63 and a beta of 0.44.

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 21st. Shareholders of record on Friday, June 7th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Thursday, June 6th. This represents a $0.64 annualized dividend and a yield of 1.15%. Exponent’s dividend payout ratio (DPR) is presently 51.20%.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

Recommended Story: Quick Ratio

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.